Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For WES
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 97.87 1.51 0.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -13.97 12.54 14.58
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 11.57 8.52 7.63
Cash 8.09 0.78 0.72
Capex 2.37 -0.51 -0.52
Free Cash Flow -20.50 0.59 0.74
Revenue 3.30 2.34 2.26
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 4.58 0.55 0.53
Operating Margin 8.61 0.46 0.42
ROA 101.99 0.05 0.02
ROE 77.82 0.18 0.10
ROIC 14.66 0.04 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of WES is permitted for members.
5 Growth
The "Growth Entry" for the Focus of WES is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of WES is permitted for members.